Technical Analysis for CING - Cingulate Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.56 | 1.79% | 0.08 |
CING closed up 9.27 percent on Wednesday, November 20, 2024, on 2.36 times normal volume. It ran into resistance at its 50 day moving average. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Flat | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 50 DMA Resistance | Bearish | 1.79% | |
| Shooting Star Candlestick | Bearish | 1.79% | |
| Pocket Pivot | Bullish Swing Setup | 1.79% | |
| Wide Bands | Range Expansion | 1.79% | |
| Gapped Up | Strength | 1.79% | |
| Upper Bollinger Band Touch | Strength | 1.79% | |
| Crossed Above 20 DMA | Bullish | 11.22% | |
| Calm After Storm | Range Contraction | 11.22% | |
| NR7 | Range Contraction | 11.22% | |
| NR7-2 | Range Contraction | 11.22% |
| Alert | Time |
|---|---|
| Rose Above Upper Bollinger Band | about 2 hours ago |
| 50 DMA Resistance | about 2 hours ago |
| Up 5% | about 2 hours ago |
| Up 3% | about 2 hours ago |
| Up 2% | about 2 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/08/2024
Cingulate Inc. is a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), Cingulate is identifying and evaluating additional therapeutic areas where PTR technology may be employed to develop future product candidates.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Products Neuroscience Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pharmaceutical Products Neuroscience Attention Deficit Hyperactivity Disorder Amphetamine Methylphenidate Adhd Educational Psychology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 152.4 |
| 52 Week Low | 1.8001 |
| Average Volume | 188,622 |
| 200-Day Moving Average | 8.17 |
| 50-Day Moving Average | 4.57 |
| 20-Day Moving Average | 4.08 |
| 10-Day Moving Average | 4.10 |
| Average True Range | 0.44 |
| RSI (14) | 53.27 |
| ADX | 13.97 |
| +DI | 36.00 |
| -DI | 20.24 |
| Chandelier Exit (Long, 3 ATRs) | 3.91 |
| Chandelier Exit (Short, 3 ATRs) | 4.34 |
| Upper Bollinger Bands | 4.81 |
| Lower Bollinger Band | 3.36 |
| Percent B (%b) | 0.77 |
| BandWidth | 35.64 |
| MACD Line | -0.13 |
| MACD Signal Line | -0.22 |
| MACD Histogram | 0.0928 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.59 | ||||
| Resistance 3 (R3) | 5.65 | 5.33 | 5.41 | ||
| Resistance 2 (R2) | 5.33 | 5.05 | 5.31 | 5.35 | |
| Resistance 1 (R1) | 4.91 | 4.88 | 5.12 | 4.85 | 5.28 |
| Pivot Point | 4.59 | 4.59 | 4.70 | 4.56 | 4.59 |
| Support 1 (S1) | 4.16 | 4.31 | 4.38 | 4.11 | 3.68 |
| Support 2 (S2) | 3.85 | 4.13 | 3.82 | 3.61 | |
| Support 3 (S3) | 3.42 | 3.85 | 3.55 | ||
| Support 4 (S4) | 3.37 |
